Click for best price
Cancer Diagnostics Market Size, Share 2024
| Market size in 2023 |
US$ 151220 million
|
Forecast Market size by 2030 |
US$ 218820 million
|
| Growth Rate |
CAGR of 5.4% |
Number of Pages |
89 Pages |
This research report provides a comprehensive analysis of the Cancer Diagnostics market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Cancer Diagnostics market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Cancer Diagnostics, challenges faced by the industry, and potential opportunities for market players.
The global Cancer Diagnostics market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Cancer Diagnostics market presents opportunities for various stakeholders, including Breast Cancer, Lung Cancer. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Cancer Diagnostics market. Additionally, the growing consumer demand present avenues for market expansion.
The global Cancer Diagnostics market was valued at US$ 151220 million in 2023 and is projected to reach US$ 218820 million by 2030, at a CAGR of 5.4% during the forecast period.
Key Features:
The research report on the Cancer Diagnostics market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Cancer Diagnostics market.
Market Overview: The report provides a comprehensive overview of the Cancer Diagnostics market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Platform-based, Instrument-based), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Cancer Diagnostics market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Cancer Diagnostics market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Cancer Diagnostics market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Cancer Diagnostics market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Cancer Diagnostics market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Cancer Diagnostics market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Cancer Diagnostics, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Cancer Diagnostics market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Cancer Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Platform-based
Instrument-based
Market segment by Application
Breast Cancer
Lung Cancer
Colorectal Cancer
Others
Global Cancer Diagnostics Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Becton, Dickinson and Company
GE Healthcare
Abbott
Roche
Thermo Fisher Scientific
Agilent Technologies
Illumina
Siemens Healthcare
C.R. Bard
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Diagnostics, market overview.
Chapter 2: Global Cancer Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Cancer Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cancer Diagnostics Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 151220 million
|
| Forecast Market size by 2030 |
US$ 218820 million
|
| Growth Rate |
CAGR of 5.4% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
89 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Diagnostics Overall Market Size
2.1 Global Cancer Diagnostics Market Size: 2023 VS 2030
2.2 Global Cancer Diagnostics Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Diagnostics Players in Global Market
3.2 Top Global Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Cancer Diagnostics Companies in Global Market, by Revenue in 2023
3.5 Global Companies Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Cancer Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Diagnostics Market Size Markets, 2023 & 2030
4.1.2 Platform-based
4.1.3 Instrument-based
4.2 By Type - Global Cancer Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Cancer Diagnostics Revenue, 2019-2024
4.2.2 By Type - Global Cancer Diagnostics Revenue, 2025-2030
4.2.3 By Type - Global Cancer Diagnostics Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Diagnostics Market Size, 2023 & 2030
5.1.2 Breast Cancer
5.1.3 Lung Cancer
5.1.4 Colorectal Cancer
5.1.5 Others
5.2 By Application - Global Cancer Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Cancer Diagnostics Revenue, 2019-2024
5.2.2 By Application - Global Cancer Diagnostics Revenue, 2025-2030
5.2.3 By Application - Global Cancer Diagnostics Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Cancer Diagnostics Market Size, 2023 & 2030
6.2 By Region - Global Cancer Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Cancer Diagnostics Revenue, 2019-2024
6.2.2 By Region - Global Cancer Diagnostics Revenue, 2025-2030
6.2.3 By Region - Global Cancer Diagnostics Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Cancer Diagnostics Revenue, 2019-2030
6.3.2 US Cancer Diagnostics Market Size, 2019-2030
6.3.3 Canada Cancer Diagnostics Market Size, 2019-2030
6.3.4 Mexico Cancer Diagnostics Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Cancer Diagnostics Revenue, 2019-2030
6.4.2 Germany Cancer Diagnostics Market Size, 2019-2030
6.4.3 France Cancer Diagnostics Market Size, 2019-2030
6.4.4 U.K. Cancer Diagnostics Market Size, 2019-2030
6.4.5 Italy Cancer Diagnostics Market Size, 2019-2030
6.4.6 Russia Cancer Diagnostics Market Size, 2019-2030
6.4.7 Nordic Countries Cancer Diagnostics Market Size, 2019-2030
6.4.8 Benelux Cancer Diagnostics Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Cancer Diagnostics Revenue, 2019-2030
6.5.2 China Cancer Diagnostics Market Size, 2019-2030
6.5.3 Japan Cancer Diagnostics Market Size, 2019-2030
6.5.4 South Korea Cancer Diagnostics Market Size, 2019-2030
6.5.5 Southeast Asia Cancer Diagnostics Market Size, 2019-2030
6.5.6 India Cancer Diagnostics Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Cancer Diagnostics Revenue, 2019-2030
6.6.2 Brazil Cancer Diagnostics Market Size, 2019-2030
6.6.3 Argentina Cancer Diagnostics Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Diagnostics Revenue, 2019-2030
6.7.2 Turkey Cancer Diagnostics Market Size, 2019-2030
6.7.3 Israel Cancer Diagnostics Market Size, 2019-2030
6.7.4 Saudi Arabia Cancer Diagnostics Market Size, 2019-2030
6.7.5 UAE Cancer Diagnostics Market Size, 2019-2030
7 Cancer Diagnostics Companies Profiles
7.1 Becton, Dickinson and Company
7.1.1 Becton, Dickinson and Company Company Summary
7.1.2 Becton, Dickinson and Company Business Overview
7.1.3 Becton, Dickinson and Company Cancer Diagnostics Major Product Offerings
7.1.4 Becton, Dickinson and Company Cancer Diagnostics Revenue in Global Market (2019-2024)
7.1.5 Becton, Dickinson and Company Key News & Latest Developments
7.2 GE Healthcare
7.2.1 GE Healthcare Company Summary
7.2.2 GE Healthcare Business Overview
7.2.3 GE Healthcare Cancer Diagnostics Major Product Offerings
7.2.4 GE Healthcare Cancer Diagnostics Revenue in Global Market (2019-2024)
7.2.5 GE Healthcare Key News & Latest Developments
7.3 Abbott
7.3.1 Abbott Company Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Cancer Diagnostics Major Product Offerings
7.3.4 Abbott Cancer Diagnostics Revenue in Global Market (2019-2024)
7.3.5 Abbott Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche Cancer Diagnostics Major Product Offerings
7.4.4 Roche Cancer Diagnostics Revenue in Global Market (2019-2024)
7.4.5 Roche Key News & Latest Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Company Summary
7.5.2 Thermo Fisher Scientific Business Overview
7.5.3 Thermo Fisher Scientific Cancer Diagnostics Major Product Offerings
7.5.4 Thermo Fisher Scientific Cancer Diagnostics Revenue in Global Market (2019-2024)
7.5.5 Thermo Fisher Scientific Key News & Latest Developments
7.6 Agilent Technologies
7.6.1 Agilent Technologies Company Summary
7.6.2 Agilent Technologies Business Overview
7.6.3 Agilent Technologies Cancer Diagnostics Major Product Offerings
7.6.4 Agilent Technologies Cancer Diagnostics Revenue in Global Market (2019-2024)
7.6.5 Agilent Technologies Key News & Latest Developments
7.7 Illumina
7.7.1 Illumina Company Summary
7.7.2 Illumina Business Overview
7.7.3 Illumina Cancer Diagnostics Major Product Offerings
7.7.4 Illumina Cancer Diagnostics Revenue in Global Market (2019-2024)
7.7.5 Illumina Key News & Latest Developments
7.8 Siemens Healthcare
7.8.1 Siemens Healthcare Company Summary
7.8.2 Siemens Healthcare Business Overview
7.8.3 Siemens Healthcare Cancer Diagnostics Major Product Offerings
7.8.4 Siemens Healthcare Cancer Diagnostics Revenue in Global Market (2019-2024)
7.8.5 Siemens Healthcare Key News & Latest Developments
7.9 C.R. Bard
7.9.1 C.R. Bard Company Summary
7.9.2 C.R. Bard Business Overview
7.9.3 C.R. Bard Cancer Diagnostics Major Product Offerings
7.9.4 C.R. Bard Cancer Diagnostics Revenue in Global Market (2019-2024)
7.9.5 C.R. Bard Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Diagnostics Market Opportunities & Trends in Global Market
Table 2. Cancer Diagnostics Market Drivers in Global Market
Table 3. Cancer Diagnostics Market Restraints in Global Market
Table 4. Key Players of Cancer Diagnostics in Global Market
Table 5. Top Cancer Diagnostics Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Cancer Diagnostics Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Cancer Diagnostics Revenue Share by Companies, 2019-2024
Table 8. Global Companies Cancer Diagnostics Product Type
Table 9. List of Global Tier 1 Cancer Diagnostics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Diagnostics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Cancer Diagnostics Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Cancer Diagnostics Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Cancer Diagnostics Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Cancer Diagnostics Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Cancer Diagnostics Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Cancer Diagnostics Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Cancer Diagnostics Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Cancer Diagnostics Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Cancer Diagnostics Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Cancer Diagnostics Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Cancer Diagnostics Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Cancer Diagnostics Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Cancer Diagnostics Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Cancer Diagnostics Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Cancer Diagnostics Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Cancer Diagnostics Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Cancer Diagnostics Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Cancer Diagnostics Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Cancer Diagnostics Revenue, (US$, Mn), 2025-2030
Table 30. Becton, Dickinson and Company Company Summary
Table 31. Becton, Dickinson and Company Cancer Diagnostics Product Offerings
Table 32. Becton, Dickinson and Company Cancer Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 33. Becton, Dickinson and Company Key News & Latest Developments
Table 34. GE Healthcare Company Summary
Table 35. GE Healthcare Cancer Diagnostics Product Offerings
Table 36. GE Healthcare Cancer Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 37. GE Healthcare Key News & Latest Developments
Table 38. Abbott Company Summary
Table 39. Abbott Cancer Diagnostics Product Offerings
Table 40. Abbott Cancer Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 41. Abbott Key News & Latest Developments
Table 42. Roche Company Summary
Table 43. Roche Cancer Diagnostics Product Offerings
Table 44. Roche Cancer Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 45. Roche Key News & Latest Developments
Table 46. Thermo Fisher Scientific Company Summary
Table 47. Thermo Fisher Scientific Cancer Diagnostics Product Offerings
Table 48. Thermo Fisher Scientific Cancer Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 49. Thermo Fisher Scientific Key News & Latest Developments
Table 50. Agilent Technologies Company Summary
Table 51. Agilent Technologies Cancer Diagnostics Product Offerings
Table 52. Agilent Technologies Cancer Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 53. Agilent Technologies Key News & Latest Developments
Table 54. Illumina Company Summary
Table 55. Illumina Cancer Diagnostics Product Offerings
Table 56. Illumina Cancer Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 57. Illumina Key News & Latest Developments
Table 58. Siemens Healthcare Company Summary
Table 59. Siemens Healthcare Cancer Diagnostics Product Offerings
Table 60. Siemens Healthcare Cancer Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 61. Siemens Healthcare Key News & Latest Developments
Table 62. C.R. Bard Company Summary
Table 63. C.R. Bard Cancer Diagnostics Product Offerings
Table 64. C.R. Bard Cancer Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 65. C.R. Bard Key News & Latest Developments
List of Figures
Figure 1. Cancer Diagnostics Segment by Type in 2023
Figure 2. Cancer Diagnostics Segment by Application in 2023
Figure 3. Global Cancer Diagnostics Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Cancer Diagnostics Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Cancer Diagnostics Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Diagnostics Revenue in 2023
Figure 8. By Type - Global Cancer Diagnostics Revenue Market Share, 2019-2030
Figure 9. By Application - Global Cancer Diagnostics Revenue Market Share, 2019-2030
Figure 10. By Type - Global Cancer Diagnostics Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Cancer Diagnostics Revenue Market Share, 2019-2030
Figure 12. By Application - Global Cancer Diagnostics Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Cancer Diagnostics Revenue Market Share, 2019-2030
Figure 14. By Region - Global Cancer Diagnostics Revenue Market Share, 2019-2030
Figure 15. By Country - North America Cancer Diagnostics Revenue Market Share, 2019-2030
Figure 16. US Cancer Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Cancer Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Cancer Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Cancer Diagnostics Revenue Market Share, 2019-2030
Figure 20. Germany Cancer Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 21. France Cancer Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Cancer Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Cancer Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Cancer Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Cancer Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Cancer Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Cancer Diagnostics Revenue Market Share, 2019-2030
Figure 28. China Cancer Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Cancer Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Cancer Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Cancer Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 32. India Cancer Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Cancer Diagnostics Revenue Market Share, 2019-2030
Figure 34. Brazil Cancer Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Cancer Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Cancer Diagnostics Revenue Market Share, 2019-2030
Figure 37. Turkey Cancer Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Cancer Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Cancer Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Cancer Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 41. Becton, Dickinson and Company Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. GE Healthcare Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Abbott Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Roche Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Thermo Fisher Scientific Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Agilent Technologies Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Illumina Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Siemens Healthcare Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. C.R. Bard Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
